Simple Lab Tests to Better Stratify Low Flow and Low Gradient AS Patients

Combining B-type natriuretic peptide (BNP) and high-sensitive cardiac troponin T measures undeniably helps to better stratify severe aortic stenosis patients with low flow and low gradient.  Many patients in these conditions clearly benefit from a transcatheter aortic valve replacement (TAVR) procedure, and for others it is simply useless, and given its high cost, better stratification could be of great use.  

Análisis de laboratorio sencillos para estratificar mejor el bajo flujo y bajo gradienteWe did know high BNP is associated with increased mortality in severe aortic stenosis patients (especially those with low flow and low gradient) but we ignored the incremental prognosis value of high-sensitive troponin level in these patients.

 

The study included 98 patients (74±10 years; 75% men) with low flow and low gradient aortic stenosis (ejection fraction <50% and/or stroke volume index  <35 ml/m², mean gradient <40 mmHg, indexed aortic valve area <0.6 cm²/m²), prospectively enrolled in the TOPAS trial (Truly or Pseudo-Severe Aortic Stenosis).


Read also: Direct Stenting vs. Conventional Angioplasty and Their Interaction with Thrombus Aspiration.


Patients were divided in three groups according to these levels: group 1, BNP <550 pg/ml and troponin <15 ng/ml; group 2, BNP ≥550 pg/ml or troponin ≥15 ng/ml; and group 3, with elevated levels (BNP ≥550 pg/ml and troponin ≥15 ng/ml).

 

Primary end point was all cause mortality.

 

27% of patients were found in group A, 40% in group B and 33% in group C. Two- year mortality rate was significantly higher in group C (41 ± 9%) compared against group B (23 ± 7%) and group A (5 ± 4%), (p<0.002 for all combinations).


Read also: An Effort Worth Your While: Rechanneling vs. Optimal Medical Treatment in Total Occlusions.


Group B did not show significant differences in mortality, regardless the higher level was BNP or troponin.

 

After adjusting for age, type of treatment (valve replacement or conservative treatment) associated coronary disease or ejection fraction, group C combined markers continued to be independent predictors of mortality (more than 4 times higher; p=0.023). Group B showed higher mortality compared to group A, though not significantly higher.

 

Conclusion

This study shows the use of combining BNP and troponin levels to clearly stratify these patients that, not long ago, were considered similar. High levels of these markers in the context of severe aortic stenosis with low flow and low gradient could determine the futility of aortic valve replacement.

 

Original title: B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis. A Substudy of the TOPAS Study.

Reference: Abdellaziz Dahou et al. J Am Coll Cardiol Img 2018, Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...